InnerScope Hearing Technologies Forms Strategic Alliance in Ainnova Tech's Acquisition of OTCHealth Inc., Unlocking National Retail Reach and Accelerating Global Hearing Innovation

Rhea-AI Summary

InnerScope Hearing Technologies (OTC: INND) announced a strategic alliance tied to Ainnova Tech's pending acquisition of OTCHealth on October 22, 2025. InnerScope will transition the majority of its day-to-day sales operations and its retail agreements with Walmart, CVS, Target, Walgreens and a network representing 15,000+ independent pharmacies to OTCHealth as a new Ainnova subsidiary.

InnerScope will receive equity and profit participation in OTCHealth and Ainnova post-acquisition, while refocusing on global R&D and hearing-technology integration with Ainnova's AI diagnostics and upcoming retinal camera to support earlier detection of vascular, neurological, and hearing-related conditions.

Positive

• Retail agreements include Walmart, CVS, Target, Walgreens and 15,000+ independent pharmacies
• InnerScope to receive equity and profit participation in OTCHealth and Ainnova post-acquisition
• Integration with Ainnova's AI diagnostics and retinal camera could enable earlier detection workflows

Negative

• Transaction is described as pending and subject to terms, not finalized
• No purchase price, equity percentages, or closing timeline were disclosed

ROSEVILLE, Calif., Oct. 22, 2025 /PRNewswire/ -- InnerScope Hearing Technologies Inc. (OTC: INND), a publicly traded innovator in hearing health ("InnerScope"), today announced its pivotal role in the pending acquisition of OTCHealth Inc. ("OTCHealth") by Ainnova Tech Inc. ("Ainnova"), a global leader in AI-powered early disease detection. This transaction marks a major milestone for InnerScope, as it leverages its established retail distribution agreements and technology pipeline to drive growth and innovation across the U.S. and global healthcare markets.

InnerScope ($INND), Ainnova Tech, & OTCHealth bring advanced OTC hearing solutions & early disease detection to millions

As an equity owner in OTCHealth, InnerScope will strategically transition the majority of its day-to-day sales operations—including its retail agreements with Walmart, CVS, Target, Walgreens, and other leading U.S. retailers and healthcare service companies representing 15,000+ independent pharmacies —to OTCHealth. This move enables OTCHealth, as a new subsidiary of Ainnova, to maximize the value of these partnerships and deliver advanced, affordable preventive health and hearing solutions to millions of consumers nationwide.

"This alliance with Ainnova Tech and OTCHealth represents a tremendous opportunity to expand the reach of our hearing technologies and to participate in the next generation of preventive healthcare," said Matthew Moore, CEO of InnerScope Hearing Technologies. "By focusing our resources on global R&D and technology innovation, while OTCHealth and Ainnova leverage our retail footprint and distribution expertise, we are positioned to deliver even greater value to patients, providers, and our shareholders."

Vinicio Vargas, CEO of Ainnova Tech, added:
"We are thrilled to welcome InnerScope as a strategic partner in this transformative acquisition. Their retail reach and hearing technology expertise are a perfect complement to Ainnova's AI-driven diagnostics platform. Together, we are building a comprehensive, accessible, and predictive healthcare ecosystem that empowers consumers and providers to detect and address health issues earlier, more efficiently, and at scale."

Shareholder Benefits and Strategic Growth

Through this transaction, subject to the terms, InnerScope will receive equity and profit participation in both OTCHealth and Ainnova Tech post-acquisition. This dual equity stake uniquely positions InnerScope shareholders to benefit from the anticipated growth, expanded market reach, and operational scale created by the combined strengths of all three companies.

InnerScope will focus on advancing its proprietary hearing technologies and bringing new innovations to market worldwide. These advancements will be integrated into OTCHealth's offerings, further enhancing the value proposition for all parties and supporting Ainnova's mission to deliver AI-driven early disease detection and preventive care.

Driving Preventive Healthcare Innovation

The alliance is built on the shared recognition that hearing loss is not only a major health issue affecting 1.5 billion people globally but is also clinically linked to chronic diseases like diabetes and cognitive decline. By integrating InnerScope's hearing healthcare expertise, OTCHealth's digital health platform, and Ainnova proprietary AI diagnostics—including advanced retinal imaging and multi-modal analytics—the partnership will enable earlier identification of vascular, neurological, and hearing-related conditions, opening new pathways for proactive diagnosis and treatment.

With Ainnova Tech's upcoming launch of its autonomous retinal camera, cloud-based analytics, and expansion into public markets, InnerScope is proud to be a foundational partner in building a more predictive, connected, and accessible model of global healthcare.

About InnerScope Hearing Technologies Inc. (OTC: INND)

InnerScope Hearing Technologies is a publicly traded company and a recognized innovator in hearing healthcare space. InnerScope holds retail agreements with leading U.S. pharmacy and retail chains and is focused on developing advanced hearing technologies for the global market. Through its equity ownership in OTCHealth and Ainnova Tech, InnerScope is positioned to benefit from ongoing growth and innovation in preventive healthcare.

About OTCHealth Inc.

OTCHealth Inc. delivers innovative digital health solutions and affordable medical, health, and wellness products online and through major U.S. pharmacies and retail chains. Its offerings include Bluetooth™ app-controlled over-the-counter hearing aids, a web-based AI hearing screening test, and an integrated guidance system for prevention and treatment—accessible via kiosks or online. For more information, please visit: https://otchealth.com

About Ainnova Tech Inc.

Ainnova Tech Inc. is a health technology company pioneering early disease detection through artificial intelligence and advanced imaging. Its proprietary platform combines deep learning, multi-modal data integration, and cloud-based analytics to deliver predictive, accessible, and connected preventive health solutions for healthcare systems and consumers worldwide. For more information, please visit: https://www.ainnovatech.com 

Safe Harbor

This news release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended intended to be covered by the "safe harbor" created by those sections. Any statements that are not historical facts contained in this press release are also "forward-looking statements," as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA). Such statements may be identified by words such as "expects," "plans," "projects," "will," "may," "anticipates," "believes," "should," "intends," "estimates," and other words of similar meaning. Such forward-looking statements are based on current expectations, involve known and unknown risks, a reliance on third parties for information, transactions or orders that may be canceled, and other factors that may cause our actual results, performance or achievements, or developments in our industry, to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from anticipated results include risks and uncertainties related to the fluctuation of global economic conditions, the performance of management and our employees, our ability to obtain financing or maintain contractual relationships with vendors and customers, competition, general economic conditions and other factors that are detailed in our periodic reports filed with the Securities and Exchange Commission ("S.E.C."). We intend that all forward-looking statements be subject to the safe-harbor provisions of the PSLRA, Securities Act, and Securities Exchange Act.

Investor Relations:
InnerScope Hearing Technologies
investor@innd.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/innerscope-hearing-technologies-forms-strategic-alliance-in-ainnova-techs-acquisition-of-otchealth-inc-unlocking-national-retail-reach-and-accelerating-global-hearing-innovation-302591168.html

SOURCE InnerScope Hearing Technologies, Inc.

FAQ

What did InnerScope (INND) announce on October 22, 2025 about OTCHealth and Ainnova?

InnerScope announced a strategic alliance in Ainnova Tech's pending acquisition of OTCHealth, transitioning sales operations and retail agreements to OTCHealth and receiving equity and profit participation.

Which retail partners are part of InnerScope's distribution footprint being transitioned to OTCHealth (INND)?

InnerScope's retail agreements include Walmart, CVS, Target, Walgreens and relationships representing 15,000+ independent pharmacies.

How will the INND-Ainnova-OTCHealth alliance affect InnerScope shareholders?

InnerScope shareholders are expected to benefit via equity and profit participation in OTCHealth and Ainnova post-acquisition, per the announcement.

Does the press release disclose the purchase price or closing date for Ainnova's acquisition of OTCHealth involving INND?

No; the announcement states the transaction is pending and subject to terms and does not disclose price, equity percentages, or a closing timeline.

What technology integration did InnerScope (INND) describe with Ainnova's platform?

InnerScope will integrate its hearing technologies into OTCHealth offerings alongside Ainnova's AI-driven diagnostics, including an upcoming autonomous retinal camera and cloud analytics to support early detection.